Exploring Clec9a in dendritic cell-based tumor immunotherapy for molecular insights and therapeutic potentials
The pivotal role of type 1 conventional dendritic cells (cDC1s) in the field of dendritic cell (DC)-based tumor immunotherapies has been gaining in…
